Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › New Rochelle › NPI 1720414154
Hospital

Montefiore New Rochelle Hospital

Montefiore New Rochelle Hospital was paid $24.11M by Medicaid between Jan 2018 and Dec 2024, across 231 billing codes. Its largest line is 99282, Emergency department visit for the evaluation and management, low to moderate severity — 19% of everything it billed.

33Billing provider infoMONTEFIORE NEW ROCHELLE HOSPITAL
NEW ROCHELLE, NY 10801
33aNPI1720414154assigned 09/17/2013
33bProvider typeGeneral Acute Care Hospital
28Total paid$24.11M
24GClaims435,790
24DCodes billed231
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#55 of 231
Median peer was paid$561K
This provider vs. median43×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201811,043$523K
201937,735$2.23M
202057,631$3.29M
202181,888$4.40M
202295,491$5.12M
202390,749$5.07M
2024incomplete61,253$3.47M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99282 Emergency department visit for the evaluation and management, low to moderate severity 19% 38,718 27,719 $4.66M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 16% 45,797 21,753 $3.91M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 11% 18,151 15,355 $2.54M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 4.7% 4,380 4,147 $1.13M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 3.9% 9,152 5,725 $948K
70450 Computed tomography, head or brain; without contrast material 3.1% 2,843 2,786 $748K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2.8% 4,787 4,675 $678K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2.5% 4,399 4,162 $606K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2.5% 4,254 3,896 $606K
80053 Comprehensive metabolic panel 2.4% 27,155 25,553 $581K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 2.3% 3,925 3,916 $556K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.2% 2,073 2,049 $525K
219 more codes
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 1.8% 2,982 $426K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.6% 2,571 $380K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.5% 1,448 $370K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.5% 554 $370K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1.4% 2,444 $347K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.3% 11,035 $309K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.2% 1,409 $284K
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.1% 374 $269K
99285 Emergency room visit (most serious) 1.1% 1,929 $264K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 295 $227K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 568 $193K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,723 $190K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 4,558 $162K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 2,452 $140K
86850 <1% 2,668 $100K
76819 Fetal biophysical profile; without non-stress testing <1% 2,507 $99K
59025 Fetal non-stress test <1% 1,756 $98K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 1,906 $97K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,888 $93K
96361 Intravenous infusion, hydration; each additional hour <1% 349 $89K
80061 Lipid panel <1% 7,522 $84K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,571 $78K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 2,029 $73K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 489 $71K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 5,199 $70K
86901 <1% 2,668 $69K
86480 <1% 1,021 $61K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,240 $60K
83655 <1% 3,215 $56K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 6,277 $53K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,875 $52K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 321 $51K
86900 <1% 2,669 $50K
77067 Screening mammography, bilateral, including computer-aided detection <1% 645 $50K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,228 $50K
76801 <1% 548 $48K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 467 $42K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 10,011 $40K
99381 <1% 291 $36K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,200 $35K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,195 $35K
99442 <1% 363 $32K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 12,420 $32K
76641 <1% 888 $32K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 435 $31K
83880 <1% 1,057 $29K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 82 $29K
90686 <1% 2,293 $28K
83036 Hemoglobin; glycosylated (A1C) <1% 3,955 $24K
99173 <1% 2,338 $24K
90715 <1% 938 $24K
85610 <1% 6,045 $22K
84443 Thyroid stimulating hormone (TSH) <1% 3,643 $22K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 21,624 $22K
76830 Ultrasound, transvaginal <1% 317 $21K
99203 Doctor's office visit, new patient (routine) <1% 135 $19K
76818 <1% 569 $19K
99201 <1% 142 $19K
80048 Basic metabolic panel (calcium, ionized) <1% 1,177 $18K
90671 <1% 923 $17K
90832 Psychotherapy session, about 30 minutes <1% 126 $17K
97803 <1% 487 $16K
99441 <1% 143 $16K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 280 $16K
99443 <1% 149 $14K
76376 <1% 2,343 $14K
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit <1% 97 $14K
80076 <1% 1,145 $13K
12001 <1% 27 $13K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 102 $12K
84439 <1% 1,959 $12K
90670 <1% 709 $11K
0001A <1% 333 $11K
0002A <1% 301 $11K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,366 $11K
88399 <1% 506 $10K
71046 Radiologic examination, chest; 2 views <1% 4,485 $10K
90698 <1% 648 $9K
82803 <1% 296 $8K
90680 <1% 506 $8K
81001 <1% 9,476 $8K
J3490 Unclassified drugs <1% 1,005 $8K
96375 Therapeutic injection; each additional sequential IV push <1% 5,037 $8K
J7030 Infusion, normal saline solution , 1000 cc <1% 8,501 $8K
90716 <1% 289 $8K
90651 <1% 154 $7K
90656 <1% 359 $7K
72125 Computed tomography, cervical spine; without contrast material <1% 102 $7K
90697 <1% 536 $7K
90681 <1% 549 $7K
88312 <1% 123 $6K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 895 $6K
71045 Radiologic examination, chest; single view <1% 2,444 $6K
84702 <1% 2,028 $6K
87088 <1% 2,885 $5K
82607 <1% 641 $5K
97802 <1% 115 $5K
90633 <1% 476 $5K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 27 $5K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 46 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,624 $4K
86769 <1% 120 $4K
90461 <1% 2,046 $4K
88142 <1% 138 $4K
90707 <1% 212 $4K
0011A <1% 110 $4K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,289 $4K
71275 Computed tomographic angiography, chest, with contrast material <1% 13 $4K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 444 $4K
0012A <1% 82 $4K
92551 <1% 126 $3K
82728 <1% 470 $3K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 5,119 $3K
82043 <1% 761 $3K
85730 <1% 2,146 $3K
86803 <1% 520 $2K
99384 <1% 18 $2K
0071A <1% 117 $2K
0072A <1% 99 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 131 $2K
72131 <1% 13 $2K
0003A <1% 45 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 938 $2K
87340 <1% 377 $2K
90734 <1% 67 $2K
84484 <1% 2,774 $2K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 12 $2K
81025 <1% 572 $2K
90620 <1% 151 $2K
91322 <1% 29 $2K
86592 <1% 976 $2K
72100 <1% 315 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,331 $1K
73630 <1% 614 $1K
83690 <1% 3,716 $1K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 655 $1K
82550 <1% 1,896 $1K
73610 <1% 319 $1K
87536 <1% 12 $1K
87420 <1% 215 $1K
90474 <1% 1,408 $1K
36415 Collection of venous blood by venipuncture <1% 807 $946.91
86580 <1% 153 $936.66
J2704 Injection, propofol, 10 mg <1% 730 $924.36
96368 <1% 24 $757.24
90733 <1% 139 $745.55
J8540 Dexamethasone, oral, 0.25 mg <1% 445 $732.62
90480 <1% 77 $728.21
73130 <1% 313 $681.41
86140 <1% 213 $634.40
83540 <1% 167 $606.54
J2270 Injection, morphine sulfate, up to 10 mg <1% 863 $582.61
82746 <1% 61 $562.63
73562 <1% 246 $555.76
70486 <1% 15 $553.84
84153 <1% 30 $541.34
85652 <1% 511 $500.91
80050 General health panel <1% 16 $480.00
90619 <1% 12 $450.27
90685 <1% 30 $440.28
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,181 $425.56
83735 <1% 406 $422.73
86762 <1% 55 $411.68
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 567 $379.21
73030 <1% 172 $374.86
87081 <1% 879 $309.82
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 911 $300.66
90710 <1% 16 $243.79
J7120 Ringers lactate infusion, up to 1000 cc <1% 153 $239.77
73110 <1% 75 $238.91
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 12 $231.72
82570 <1% 78 $230.45
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 82 $217.87
84480 <1% 69 $217.52
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 827 $178.79
73564 <1% 46 $172.05
86706 <1% 29 $169.67
84156 <1% 62 $165.74
83020 <1% 25 $160.67
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 671 $157.99
82150 <1% 264 $154.48
86787 <1% 38 $141.79
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 220 $140.16
96127 <1% 131 $138.92
94760 <1% 114 $134.09
82950 <1% 38 $131.36
96380 <1% 32 $122.36
96376 <1% 181 $120.97
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 171 $115.68
87040 <1% 279 $101.77
J3010 Injection, fentanyl citrate, 0.1 mg <1% 357 $94.10
J7050 Infusion, normal saline solution, 250 cc <1% 357 $88.43
90657 <1% 26 $82.60
G8510 Screening for depression is documented as negative, a follow-up plan is not required <1% 101 $78.32
87077 <1% 40 $74.22
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,058 $70.10
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 385 $63.08
83550 <1% 27 $60.92
90472 Immunization administration, each additional vaccine (list separately) <1% 62 $60.17
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 739 $55.82
87186 <1% 25 $52.14
90696 <1% 12 $50.20
80320 <1% 461 $39.68
86038 <1% 12 $33.02
83605 <1% 103 $31.87
J0690 Injection, cefazolin sodium, 500 mg <1% 26 $25.88
81002 <1% 17 $25.83
J7510 Prednisolone oral, per 5 mg <1% 55 $10.18
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 72 $9.18
J1644 Injection, heparin sodium, per 1000 units <1% 26 $9.01
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 341 $5.34
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 66 $4.88
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 105 $3.26
J2060 Injection, lorazepam, 2 mg <1% 14 $2.58
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 26 $1.28
91300 <1% 74 $0.68
91301 <1% 73 $0.28
91307 <1% 30 $0.15
99080 0% 1,673 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKOHN, RANDI (AVP, REGULATORY PLANNING)
Same official

Other billing entities under KOHN, RANDI

Full network →
ProviderLocationPaid
Montefiore Mount Vernon HospitalMount Vernon, NY$24.60M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.